These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 9365632)

  • 1. A comparative analysis of methyl prednisone pulse versus orthoclone therapy in the management of acute cellular rejection.
    Nampoory MR; Johny KV; Costandi JN; al-Muzairai IM; Gupta RK; Nair MP; Samhan M; al-Mousawi M
    Transplant Proc; 1997 Nov; 29(7):2967-70. PubMed ID: 9365632
    [No Abstract]   [Full Text] [Related]  

  • 2. OKT3 versus methylprednisolone for primary treatment of rejection: a retrospective evaluation.
    Meijer RT; Keur I; Surachno S; ten Berge IJ; Schellekens PT
    Transplant Proc; 2001 May; 33(3):2196-7. PubMed ID: 11377501
    [No Abstract]   [Full Text] [Related]  

  • 3. ATG versus OKT3 in the treatment of steroid-resistant rejection following living-related donor renal transplantation.
    Uslu A; Tokat Y; Ok E; Unsal A; Ilkgul O; Kaplan H
    Transplant Proc; 1997 Nov; 29(7):2805-6. PubMed ID: 9365571
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of OKT3 treatment for steroid resistant rejection of renal allografts: the long-term outcome at a single center.
    Inui M; Tanabe K; Ishikawa N; Tokumoto T; Harano M; Otsubo S; Suzuki K; Goya N; Yagisawa T; Nakazawa H; Fuchinoue S; Toma H
    Transplant Proc; 1999 Nov; 31(7):2870-1. PubMed ID: 10578320
    [No Abstract]   [Full Text] [Related]  

  • 5. Effectiveness of short-term OKT3 therapy in the treatment of steroid-resistant renal allograft rejection.
    Carvalho MF; Adoni T; Saggioro FP; Soares V
    Transplant Proc; 1998 Sep; 30(6):2876-7. PubMed ID: 9745607
    [No Abstract]   [Full Text] [Related]  

  • 6. Successful therapy of chronic renal allograft failure by enhanced immunosuppression.
    Kliem V; Tiroke T; Ehlerding G; Eberhard O; Behrend M; Frei U; Koch KM; Pichlmayr R; Brunkhorst R
    Transplant Proc; 1998 Jun; 30(4):1207-9. PubMed ID: 9636490
    [No Abstract]   [Full Text] [Related]  

  • 7. Low-dose tacrolimus (FK 506)-based immunosuppressive protocol in living donor renal transplantation.
    Kokado Y; Takahara S; Kyo M; Ichimaru N; Toki K; Wang JD; Okuyama A
    Transplant Proc; 1999; 31(1-2):1151-4. PubMed ID: 10083515
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term efficacy of OKT3 for steroid-resistant acute rejection in renal transplant patients.
    Kumano K; Irie A; Mashimo S; Endo T; Koshiba K
    Transplant Proc; 1996 Jun; 28(3):1354-5. PubMed ID: 8658691
    [No Abstract]   [Full Text] [Related]  

  • 9. Predicting factors for long-term results of OKT3 therapy in steroid-resistant acute rejection following cadaveric renal transplantation.
    Rostaing L; Chabannier MH; Modesto A; Rouzaud A; Cisterne JM; Tkaczuk J; Durand D
    Transplant Proc; 1998 Jun; 30(4):1170-2. PubMed ID: 9636473
    [No Abstract]   [Full Text] [Related]  

  • 10. Tacrolimus therapy for refractory renal allograft rejection: experience with steroid withdrawal.
    Cronin DC; Bruce DS; Newell KA; Josephson MA; Millis JM; Piper JB; Ruebe M; Kirby M; Thistlethwaite JR; Woodle ES
    Transplant Proc; 1997; 29(1-2):307. PubMed ID: 9123010
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison between three different antilymphocyte induction protocols in renal transplant recipients with delayed graft function.
    Sumrani N; Hong JH; DiBenedetto A; Clayton R; Miles AM; Markell MS; Distant DA; Fleishhacker J; Sommer BG
    Transplant Proc; 1996 Feb; 28(1):400-1. PubMed ID: 8644289
    [No Abstract]   [Full Text] [Related]  

  • 12. Conversion to tacrolimus for acute corticosteroid- and antibody-resistant rejection following kidney transplantation.
    Kliem V; Radermacher J; Hiss M; Pethig M; Burg M; Brunkhorst R
    Transplant Proc; 1999 Nov; 31(7A):37S-40S. PubMed ID: 10576041
    [No Abstract]   [Full Text] [Related]  

  • 13. The impact of induction therapy HLA matching and T- and B-cell crossmatch on the long-term outcome of living donated renal transplantation.
    Lumlertgul D; Manoyos A; Saikum U; Chaovisitsaree A; Boonkaew S; Wongsawad P; Bunnachak D; Roachanapiwat B; Wutikarn S
    Transplant Proc; 1998 Aug; 30(5):1801-4. PubMed ID: 9723290
    [No Abstract]   [Full Text] [Related]  

  • 14. Prophylactic OKT3, CyA, and steroids versus antilymphoblast globulin, CyA, and steroids in cadaveric kidney transplantation.
    Griñó JM; Castelao AM; Serón D; Gonzalez C; Galceran JM; Gil-Vernet S; Andrés E; Bover J; Torras J; Alsina J
    Transplant Proc; 1992 Feb; 24(1):39-41. PubMed ID: 1539329
    [No Abstract]   [Full Text] [Related]  

  • 15. Renal transplantation in children less than six years old.
    Garcia CD; Barros V; Schneider L; Guimarães P; Didone E; Guerra EE; Vitola SP; Garcia VD
    Transplant Proc; 2001; 33(7-8):3595-6. PubMed ID: 11750527
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of HLA matching on graft survival in live donor kidney transplantations.
    Velidedeoğlu E; Bilgin N; Haberal M
    Transplant Proc; 1993 Dec; 25(6):3144-5. PubMed ID: 8266491
    [No Abstract]   [Full Text] [Related]  

  • 17. Excellent long-term survival of low-risk, first renal allografts using cyclosporine/azathioprine double therapy.
    Faull RJ; Bannister KM; Russ GR; Mathew TH; Clarkson AR
    Transplant Proc; 1999; 31(1-2):1155-6. PubMed ID: 10083516
    [No Abstract]   [Full Text] [Related]  

  • 18. Conversion of renal transplant immunosuppression from tacrolimus (FK 506) to cyclosporine: a single center experience.
    Ichikura H; Tanabe K; Tokumoto T; Shimuzu T; Ishikawa N; Harano M; Inui M; Manu M; Ito S; Shimmura H; Okuda H; Yagisawa T; Fuchinoue S; Toma H
    Transplant Proc; 2000 Nov; 32(7):1733-5. PubMed ID: 11119911
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term results of OKT3-treated renal transplant recipients.
    Tanabe K; Takahashi K; Sonda K; Tokumoto T; Koga S; Nakazawa H; Goya N; Yagisawa T; Fuchinoue S; Kawai T; Toma H; Ota K
    Transplant Proc; 1996 Jun; 28(3):1350-1. PubMed ID: 8658689
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison between methylprednisolone and OKT3 treatment for the first acute rejection episode in combined kidney and pancreas transplant recipients.
    el-Ghoroury M; Hariharan S; Munda R; Demmy AM; Schroeder TJ; Alexander JW; First MR
    Transplant Proc; 1995 Dec; 27(6):3133-4. PubMed ID: 8539879
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.